期刊文献+

miR-27a低表达对子宫内膜癌HEC-1-A细胞增殖的影响 被引量:2

The effect of low expression of miR-27a on the proliferation on endometrial cancer HEC-1-A cells
下载PDF
导出
摘要 目的 研究miR-27a低表达对子宫内膜癌HEC-1-A细胞增殖的影响。方法 构建miR-27a低表达HEC-1-A细胞株。细胞实验分为空白对照组(HEC-1-A不做任何处理)、NC-miR组(转染miR-27a空载体)及miR-27a inhibitor组(转染miR-27a抑制剂)。qRT-PCR法检测各组细胞miR-27a表达情况;MTT比色法和平板克隆技术检测各组细胞增殖能力。结果 成功构建miR-27a低表达HEC-1-A细胞株。miR-27a inhibitor组miR-27a水平及细胞增殖能力均低于NC-miR组及空白对照组(P<0.05)。结论 miR-27a低表达抑制子宫内膜癌HEC-1-A细胞增殖能力。 Aim To study the effect of low miR-27a expression on the proliferation ability of HEC-1-A cells in human endometrial cancer.Methods Low expression of miR-27a HEC-1-A cell line was established.The experiment was set as blank control group(HEC-1-A without any treatment),NC-miR group(transfected empty vector)and miR-27a inhibitor group(transfected miR-27a inhibitor).The expression of miR-27a in each group of cells was detected by qRT-PCR.The cell proliferation capacity was detected by MTT colorimetric method and plate clone formation method.Results miR-27a low-expression HEC-1-A cell line was successfully constructed.The expression of miR-27a and the cell proliferation capacity in the miR-27a inhibitor group were significantly lower than those in NC-miR group and blank control group(P<0.05).Conclusion The low expression of miR-27a inhibits the proliferation of endometrial cancer HEC-1-A cells.
作者 彭依琳 陈文欣 胡华 周建斌 PENG Yilin;CHEN Wenxin;HU Hua;ZHOU Jianbin(Department of Obstetrics and Gynecology,the Second Affiliated Hospital,Hengyang Medical School,University of South China,Hengyang 421001,Hunan,China;Department of Pathology,the Second Affiliated Hospital,Hengyang Medical School,University of South China,Hengyang 421001,Hunan,China)
出处 《中南医学科学杂志》 CAS 2023年第3期360-362,共3页 Medical Science Journal of Central South China
基金 湖南省自然科学基金项目(2021JJ70112)。
关键词 miR-27a 子宫内膜癌 增殖 HEC-1-A细胞 miR-27a endometrial carcinoma proliferation HEC-1-A cell
  • 相关文献

参考文献3

二级参考文献19

  • 1杜秋丽.miRNA及其功能研究[J].生物学通报,2004,39(8):13-15. 被引量:9
  • 2Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010 [ J ]. CA Cancer J Clin ,2010,60 (5) :277 - 300.
  • 3Tashiro H, Blazes MS,Wu R,et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other co:n~czn gynecological malignancies[ J]. Cancer Res, 1997,57 ( 18 ) :3935 - 3940.
  • 4Jimenez C, Jones DR, Rodrtguez-Viciana P,et al. Identification and characterization of a new oncogene derived from the regulatory sub- unit of phosphoinositide 3-kinase [ J ]. EMBO J, ! 998,17 ( 3 ) : 743 - 753.
  • 5Chang F, Lee JT, Navolanic PM, et aL Involvement of PL3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic trans- formation : a target for cancer chemotherapy [ J ]. Leukemia, 2003, 17(3) :590 -603.
  • 6Uegaki K, Kanamofi Y, Kigawa J, et al. PTEN - positive and phos- phorylated - Akt - negative expressign is a predictor of survival for patients with advanced endometrial carcinoma [J]. [ J ]. Oncol Rep,2005,14(2) :389 -392.
  • 7Fujita T,Doihara H,Kawasaki K,et al.. PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer [ J ]. Br J Cancer, 2006,94 : 247 - 252.
  • 8Dahia PL. PTEN, a unique tumor suppressor gene[ J ]. Endocr Re- lat Cancer,2000,7 ( 2 ) : 115- 129.
  • 9Small EM, O'Rourke JR, Moresi V, et al.. Regulation of PI3 - ki- nase/Akt signaling by muscle- enriched microRNA-486 [ J ]. Proc Natl Acad Sci USA,2010,107 (9) :4218 -4223.
  • 10Stambolic V, Tsao MS, Macpherson D, et al. High incidence of breast and endometrial neoplasia resembling human Cowden syn- drome in pten +/- mice[J]. Cancer Res,2000,60(13) :3605 -3611.

共引文献43

同被引文献30

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部